Company: BSAAR
Filing Date: 2025-03-28
Form Type: S-1
Source: 0001013762-25-004269
Chunk: 203

Company: BEST SPAC I Acquisition Corp.
Filing Date: 2025-03-28
Form: S-1
Chunk 203
---
 further described in this prospectus. The issuance of additional ordinary or preference shares to shareholders of a potential business combination target as consideration could significantly dilute the equity interest of investors in this offering. For example, if we consummate a business combination with a potential business combination target with an agreed upon consideration of $600 million assuming an all -sharetransaction, the shareholders of the potential business combination target would be issued 60 million shares, which would dilute the interest of our shareholders. Such dilution would even further increase if the anti -dilutionprovisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion of the Class B ordinary shares. See “ Founder shares conversion and anti -dilution ”. Such calculation does not reflect any dilution associated with the conversion of rights, including the private placement rights, which would cause the actual dilution to the public shareholders to be higher. Net tangible book value per share is determined by dividing our net tangible book value, which is our total tangible assets less total liabilities (including the value of Class A ordinary shares which may be redeemed for cash), by the number of issued and outstanding Class A ordinary shares. At December 31, 2024, our net tangible book value was $9,500 or approximately $0.01 per ordinary share. After giving effect to the sale of 5,500,000 Class A ordinary shares included in the units we are offering by this prospectus (or 6,325,000 Class A ordinary shares if the underwriters’ over -allotmentoption is exercised in full), the sale of the private securities and the deduction of underwriting commissions and estimated expenses of this offering, our pro forma net tangible book value at December 31, 2024 would have been $4,559,993 or $1.84 per share (or $1.78 per share if the underwriters’ over -allotmentoption is exercised in full), representing an immediate increase in net tangible book value (as decreased by the value of the approximately 5,500,000 Class A ordinary shares that may be redeemed for cash, or 6,325,000 Class A ordinary shares if the underwriters’ over -allotmentoption is exercised in full) of $1.83 per share (or $1.78 per share if the underwriters’ over -allotmentoption is exercised in full) to our initial shareholder as of the date of this prospect